Company Profile - JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED สำนักงานคณะกรรมการกำกับหลักทรัพย์และตลาดหลักทรัพย์ Printed on 09 August 2024 20:12 Company Profile JSP
1 No. ECF2 029/2561 28 June 2018 Subject The Entering into an Investment of the construction of the Manufacturing Plant and Distributing of the Medium Density Fiber Board or MDF Board in Narathiwat
1 No. ECF2 029/2561 28 June 2018 Subject The Entering into an Investment of the construction of the Manufacturing Plant and Distributing of the Medium Density Fiber Board or MDF Board in Narathiwat
Globalization and group audits : access to component auditors’ workpapers, especially in China Weaker currency could lead to an increase in manufacturing businesses : auditors’ skills for auditing manufacturing
dialysate and medical supply manufacturing and distribution, which increased from the same period of the previous year for 5.31 million baht or 22.37%, resulting in the increase of the Company Group’s gross
segments, we focus on creating innovations and managing financial products, as well as reinforcing our sales and service quality excellence, with greater consideration of consumer protection in order to
medical supply manufacturing and distribution, which increased from the same period of the previous year for 4.80 million baht or 18.99%, resulting in the increase of the Company Group’s gross profit for
vs. total revenue has increased significantly. The main factors behind this unwelcome trend was a jump in fuel (petroleum coke) prices, and increased manufacturing cost of machinery equipment. However
. Prachnon Termritikulchai who is a Director and CEO of UBIS (Asia) Public Company Limited. 3 Information : Purchase of 6 machineries (Second hand) for manufacturing Size of transaction : It is considered as
., Ltd. (“GWM”), running the business of kidney cleanser and medical supplies manufacturing and distribution, which is increase from the same quarter of the previous years for 32.58 million baht (38.59